**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: March 12, 1980
* Admit Date: January 15, 2023
* Discharge Date: January 25, 2023
* Admit Diagnosis: Type 2 Diabetes Mellitus

**Medical History:**

John Doe, a 42-year-old male, was admitted to the endocrinology unit on January 15, 2023, with a diagnosis of type 2 diabetes mellitus. He presented with symptoms of increased thirst and urination, as well as fatigue and blurred vision. His medical history revealed hypertension, hypercholesterolemia, and a family history of type 2 diabetes.

**Admission Workup:**

Upon admission, John underwent a comprehensive workup, including a fasting plasma glucose (FPG) level of 250 mg/dL (> 13.9 mmol/L), glycosylated hemoglobin (HbA1C) of 8.5%, and oral glucose tolerance testing (OGTT) with a peak glucose level of 300 mg/dL (> 16.7 mmol/L). These results confirmed the diagnosis of type 2 diabetes mellitus.

**Diagnostic Studies:**

During his hospital stay, John underwent the following diagnostic studies:

* Foot examination: normal sensation and circulation
* Funduscopic examination: no retinopathy
* Urine testing for albuminuria: negative
* Measurement of serum creatinine: 1.2 mg/dL (normal range 0.5-1.1 mg/dL)
* Lipid profile: total cholesterol 220 mg/dL, HDL cholesterol 60 mg/dL, LDL cholesterol 140 mg/dL, triglycerides 150 mg/dL

**Treatment:**

John was started on the following medications:

* Metformin 500 mg twice daily
* Insulin glargine 10 units at bedtime
* Aspirin 81 mg daily

He was also educated on the following lifestyle modifications:

* Dietary recommendations: whole foods, high-quality carbohydrates, and portion control
* Physical activity: at least 150 minutes/week, including both aerobic and resistance exercise
* Monitoring blood glucose levels and adjusting insulin doses based on carbohydrate intake

**Discharge Instructions:**

At the time of discharge, John was advised to:

* Continue metformin 500 mg twice daily
* Continue insulin glargine 10 units at bedtime
* Adjust insulin doses based on blood glucose levels and carbohydrate intake
* Monitor for signs and symptoms of hypoglycemia, hyperglycemia, and diabetic complications
* Attend regular follow-up appointments with his primary care physician and endocrinologist
* Schedule a follow-up appointment with the podiatrist for foot examination and education on foot care

**Future Plans:**

John will be followed up with his primary care physician and endocrinologist every 3-4 months to monitor his blood glucose control and adjust his medication regimen as needed. He will also be educated on the importance of regular physical activity, a balanced diet, and self-monitoring of blood glucose levels.

**Disclaimer:**

This discharge summary is a summary of the patient's hospital stay and is not intended to be a comprehensive treatment plan. The patient should follow up with their primary care physician and endocrinologist for further guidance and management of their condition.